Cancer Research UK scheme secures £280m buy-in with Standard Life

BPA deal secures the benefits of 2,800 scheme members

Holly Roach
clock • 2 min read
Cancer Research UK scheme secures £280m buy-in with Standard Life

The Cancer Research UK Pension Scheme has completed a £280m buy-in deal with Standard Life.

The bulk purchase annuity (BPA) transaction – completed in March using a "bespoke offering" – secures the benefits of 2,800 scheme members. Mercer was lead transaction adviser to the trustee, wh...

To continue reading this article...

Join Professional Pensions

Become a Professional Pensions Lite Member today

  • Three complimentary articles per month covering the latest real-time news, analysis and opinion from the industry
  • Receive important and breaking news stories via our two daily news alerts
  • Hear from industry experts and other forward-thinking leaders

Are you a trustee, investment consultant or in-house pension and benefit scheme professional? You can apply for full complimentary access here

Join now

 

Already a Professional Pensions
member?

Login

More on Risk Reduction

Cognitronics scheme completes £1.7m buy-in with Aviva

Cognitronics scheme completes £1.7m buy-in with Aviva

Risk reduction transaction secures the benefits for eight deferred members

Martin Richmond
clock 01 October 2026 • 2 min read
Competition drove BPA deals to £10.2bn in H1

Competition drove BPA deals to £10.2bn in H1

Strong pipeline of larger deals expected for H2 as insurers compete on non-price factors

Alex Levy
clock 30 September 2026 • 2 min read
UPDATED - Clara announces £135m superfund deal with Arco pension scheme

UPDATED - Clara announces £135m superfund deal with Arco pension scheme

Deal is Clara’s seventh with 2-3 more expected this year

Jonathan Stapleton
clock 29 September 2026 • 3 min read
Trustpilot